News
The ASX shook off a rocky start as banks and defensive sectors steadied nerves, Kaili surges after approval to start rare ...
From handbags to home office expenses, tax experts have revealed the surprising deductions Australians frequently forget.
Dr Boreham’s Crucible: In the shadow of giants, but can this biotech become a tumour-tackling titan?
Radiopharm Theranostics is lining up multiple shots at oncology goals. Maybe one, maybe more, will hit the back of the net.
An utterly deranged 8000% pop, and sharp plummet, at little known ASX explorer Kaili Resources blew the lid off the market today.
BHP saw its profit drop to the lowest in five years, but beat consensus on its final dividend payment with shareholders pocketing US$3bn.
The PainChek app uses AI to analyse facial muscle movements and detect pain in adults patients with dementia and cognitive impairment.
Brazilian Critical Minerals (ASX:BCM) results from Ema field trial shows high grades of rare earth oxides, magnet and heavy rare earths.
The ASX has knocked off another intraday and closing high, continuing to demonstrate steady momentum across sectors.
The last remaining ASX-listed veterinary chain, Apiam Animal Health has fielded a $124 million cash takeover offer.
BCM (ASX:BCM) has placed a critical piece of the puzzle needed to advance its flagship Ema rare earths project to development ...
Why Precision Funds Management's Dermot Woods takes a shine to biotechs that can explain their programs in simple terms.
Argonaut's David Franklyn likes the supply and demand set up for the bauxite market, with a keen eye on Queensland's Metro ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results